|
US20070117862A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6537579B1
(en)
*
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
BRPI9810945B8
(pt)
*
|
1997-06-27 |
2021-05-25 |
Abraxis Bioscience Inc |
formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
|
US6040330A
(en)
*
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
|
CA2684454A1
(en)
*
|
1999-05-21 |
2000-11-18 |
American Bioscience, Llc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
GB9920548D0
(en)
*
|
1999-08-31 |
1999-11-03 |
Rhone Poulenc Rorer Sa |
Treatment of hepatocellular carcinoma
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
ITMI20001107A1
(it)
*
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
CA2432319A1
(en)
|
2000-12-21 |
2002-07-18 |
Nektar Therapeutics |
Pulmonary delivery of polyene antifungal agents
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US6869617B2
(en)
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
KR100426636B1
(ko)
*
|
2001-05-18 |
2004-04-08 |
한국과학기술연구원 |
주사 가능한 젤 상의 조성물 및 그의 제조방법
|
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
JP2005504090A
(ja)
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
|
WO2003032906A2
(en)
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
ITMI20020681A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
|
ITMI20020680A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
|
US20030207907A1
(en)
|
2002-05-03 |
2003-11-06 |
Iversen Patrick L. |
Delivery of microparticle-conjugated drugs for inhibition of stenosis
|
|
ITMI20021392A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
|
|
CA2491312C
(en)
|
2002-07-15 |
2011-05-31 |
Alcon, Inc. |
Bioerodible film for ophthalmic drug delivery
|
|
GB0216700D0
(en)
*
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
|
IL150906A0
(en)
*
|
2002-07-25 |
2003-02-12 |
Yissum Res Dev Co |
Diagnostic microspheres
|
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
DE10234784A1
(de)
*
|
2002-07-30 |
2004-02-19 |
Günenthal GmbH |
Intravenös applizierbare, pharmazeutische Darreichungsform
|
|
CN103405405A
(zh)
*
|
2002-12-09 |
2013-11-27 |
阿布拉西斯生物科学有限责任公司 |
组合物和传递药剂的方法
|
|
KR100871529B1
(ko)
*
|
2002-12-09 |
2008-12-05 |
치아-시앙 수 |
정맥내 주사용으로 적합한 피브리노겐 입자의 제조방법
|
|
EA200501252A1
(ru)
|
2003-02-03 |
2006-02-24 |
Неофарм, Инк. |
Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
|
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
|
CN1303994C
(zh)
*
|
2003-03-03 |
2007-03-14 |
浙江海正药业股份有限公司 |
紫杉醇囊泡注射剂及其制备方法
|
|
US8476010B2
(en)
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
|
WO2005070391A2
(en)
|
2004-01-21 |
2005-08-04 |
The School Of Pharmacy |
Method of producing microparticles
|
|
KR100578382B1
(ko)
|
2004-07-16 |
2006-05-11 |
나재운 |
항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
SI1853250T1
(sl)
|
2005-02-18 |
2012-01-31 |
Abraxis Bioscience Llc |
Kombinacije in reĹľimi dajanja terapevtskih sredstev in kombinirana terapija
|
|
US20090028950A1
(en)
*
|
2005-06-29 |
2009-01-29 |
Mitsubishi Chemical Corporation |
Granule dispersion composition, process for producing the same, and granular material and medicine
|
|
KR101420445B1
(ko)
|
2005-08-31 |
2014-07-16 |
아브락시스 바이오사이언스, 엘엘씨 |
수 난용성 제약학적 약제 및 항균제를 포함하는 조성물
|
|
AU2006284657B2
(en)
*
|
2005-08-31 |
2012-07-19 |
Abraxis Bioscience, Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
US20070083186A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Darrick Carter |
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
|
|
WO2007069272A2
(en)
*
|
2005-10-21 |
2007-06-21 |
Panacea Biotec Limited |
Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
|
|
BRPI0712183A2
(pt)
*
|
2006-06-08 |
2012-01-17 |
3M Innovative Properties Co |
microesferas poliméricas e métodos de preparo de microesferas poliméricas
|
|
EP2067475A4
(en)
|
2006-09-26 |
2010-12-15 |
Astellas Pharma Inc |
PREPARATION FOR TACROLIMUS MAINTAINED RELEASE
|
|
EP3470071A1
(en)
|
2006-12-14 |
2019-04-17 |
Abraxis BioScience, LLC |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
WO2008084698A1
(ja)
|
2006-12-28 |
2008-07-17 |
Astellas Pharma Inc. |
タクロリムス徐放性医薬組成物
|
|
WO2008109163A1
(en)
|
2007-03-07 |
2008-09-12 |
Abraxis Bioscience, Llc. |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
US20100166869A1
(en)
|
2007-05-03 |
2010-07-01 |
Desai Neil P |
Methods and compositions for treating pulmonary hypertension
|
|
JP5579057B2
(ja)
|
2007-06-01 |
2014-08-27 |
アブラクシス バイオサイエンス， エルエルシー |
再発性癌の処置のための方法および組成物
|
|
WO2009097570A2
(en)
*
|
2008-01-30 |
2009-08-06 |
University Of Kansas |
Intralymphatic chemotherapy drug carriers
|
|
RU2496482C2
(ru)
|
2008-03-05 |
2013-10-27 |
Бакстер Интернэшнл Инк. |
Композиции и способы для доставки лекарственных средств
|
|
JP2011517683A
(ja)
*
|
2008-04-10 |
2011-06-16 |
アブラクシス バイオサイエンス， エルエルシー |
疎水性タキサン誘導体の組成物およびその使用
|
|
MX2010011165A
(es)
*
|
2008-04-10 |
2011-02-22 |
Abraxis Bioscience Llc |
Composiciones de derivados de taxano hidrofobos y sus usos.
|
|
WO2010003057A2
(en)
|
2008-07-03 |
2010-01-07 |
Mayo Foundation For Medical Education And Research |
Treating cancer
|
|
KR101043407B1
(ko)
*
|
2009-02-19 |
2011-06-22 |
한국과학기술연구원 |
암 표적성이 우수한 단백질 복합체 및 이의 제조방법
|
|
KR101066197B1
(ko)
|
2009-04-06 |
2011-09-20 |
한국생명공학연구원 |
코엔자임 ｑ10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
|
|
EP2416650B1
(en)
*
|
2009-04-10 |
2020-02-26 |
Abraxis BioScience, LLC |
Nanoparticle formulations and uses therof
|
|
HRP20192259T1
(hr)
|
2009-04-15 |
2020-03-06 |
Abraxis Bioscience, Llc |
Pripravci nanočestica bez priona i metode njihove proizvodnje
|
|
PL2470173T3
(pl)
*
|
2009-08-25 |
2016-11-30 |
|
Leczenie skojarzone nanocząstkowymi kompozycjami taksanu i inhibitorów hedgehog
|
|
JP4856752B2
(ja)
*
|
2009-11-30 |
2012-01-18 |
ホソカワミクロン株式会社 |
薬物含有ナノ粒子の製造方法
|
|
EP2512460A4
(en)
*
|
2009-12-18 |
2015-01-21 |
Exodos Life Sciences Ltd Partnership |
METHOD AND COMPOSITIONS FOR STABLE LIQUID ACTIVE FORMULATIONS
|
|
ES2702400T3
(es)
*
|
2010-02-03 |
2019-02-28 |
Oncbiomune Inc |
Composiciones que contienen un taxano o un taxoide y una proteína
|
|
CA3051495A1
(en)
|
2010-03-26 |
2011-09-29 |
Abraxis Bioscience, Llc |
Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
|
|
KR20130028727A
(ko)
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
|
NZ717490A
(en)
|
2010-03-29 |
2017-12-22 |
Abraxis Bioscience Llc |
Methods of treating cancer
|
|
EA027666B1
(ru)
|
2010-05-03 |
2017-08-31 |
ТЕИКОКУ ФАРМА ЮСЭй, ИНК. |
Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования
|
|
BR112012030909A2
(pt)
|
2010-06-04 |
2020-08-18 |
Abraxis Bioscience, Llc |
métodos de tratamento de câncer pancreático
|
|
WO2011156119A1
(en)
*
|
2010-06-07 |
2011-12-15 |
Abraxis Bioscience, Llc |
Combination therapy methods for treating proliferative diseases
|
|
KR101007948B1
(ko)
|
2010-08-13 |
2011-01-14 |
김지훈 |
스팀을 이용한 고무 블록의 성형 방법
|
|
US9782342B2
(en)
|
2010-10-11 |
2017-10-10 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
|
CN102670518B
(zh)
*
|
2011-03-14 |
2014-08-20 |
齐鲁制药有限公司 |
一种难溶性药物球形颗粒的制备方法
|
|
EP2694056B1
(en)
|
2011-04-01 |
2019-10-16 |
AstraZeneca AB |
Therapeutic treatment
|
|
PT2707030T
(pt)
|
2011-05-09 |
2020-05-22 |
Mayo Found Medical Education & Res |
Tratamentos de cancro
|
|
PH12014500943A1
(en)
|
2011-11-30 |
2014-06-30 |
Astrazeneca Ab |
Combination treatment of cancer
|
|
JP6216721B2
(ja)
|
2011-12-14 |
2017-10-18 |
アブラクシス バイオサイエンス， エルエルシー |
粒子を凍結乾燥または凍結するためのポリマー賦形剤の使用
|
|
WO2013115559A1
(ko)
*
|
2012-01-30 |
2013-08-08 |
성균관대학교 산학협력단 |
수난용성 약물을 내부에 포함하는 알부민 나노입자 제조방법
|
|
HRP20181187T1
(hr)
|
2012-04-04 |
2018-09-21 |
Halozyme, Inc. |
Kombinirana terapija s hijaluronidazom i taksanom koji ciljano djeluje na tumor
|
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
US10413606B2
(en)
|
2012-10-01 |
2019-09-17 |
Mayo Foundation For Medical Education And Research |
Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
EP2921166B1
(en)
*
|
2012-11-15 |
2017-06-14 |
Utah-Inha DDS & Advanced Therapeutics Research Center |
Biodegradable microbeads with improved anticancer drug adsorptivity, containing albumin and dextran sulfate, and preparation method therefor
|
|
CN104994841B
(zh)
|
2012-11-27 |
2018-11-16 |
犹他-仁荷Dds及新医疗技术开发共同研究所 |
包含阴离子性高分子的抗癌药吸附能力得到提高的生物降解性微珠及其的制备方法
|
|
CN103908432B
(zh)
*
|
2013-01-02 |
2018-09-21 |
博瑞生物医药（苏州）股份有限公司 |
一种伊沙匹隆白蛋白的冻干组合物及其制备方法
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
AU2014224445C1
(en)
|
2013-03-04 |
2017-07-27 |
Astrazeneca Ab |
Combination treatment
|
|
EP3698784A1
(en)
*
|
2013-03-12 |
2020-08-26 |
Abraxis BioScience, LLC |
Methods of treating lung cancer
|
|
EP2968191B1
(en)
|
2013-03-14 |
2021-06-16 |
Abraxis BioScience, LLC |
Methods of treating bladder cancer
|
|
KR101329646B1
(ko)
|
2013-05-02 |
2013-11-14 |
주식회사 지니스 |
표적지향증폭형 항암나노입자 및 이의 제조방법
|
|
IL228528A
(en)
|
2013-09-17 |
2015-01-29 |
Technion Res & Dev Foundation |
Potato-based nanoparticles
|
|
WO2015051349A1
(en)
*
|
2013-10-04 |
2015-04-09 |
Sorrento Therapeutics, Inc. |
Treating metastatic cancer with micellular paclitaxel
|
|
CN104758942A
(zh)
*
|
2014-01-02 |
2015-07-08 |
国家纳米科学中心 |
基于蛋白质的药理活性物质组合物及其制备方法和应用
|
|
WO2015152433A1
(en)
*
|
2014-03-31 |
2015-10-08 |
Hanmi Pharm. Co., Ltd. |
Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
|
|
WO2015187194A1
(en)
*
|
2014-06-01 |
2015-12-10 |
Crititech, Inc. |
Use of paclitaxel particles
|
|
US20150352176A1
(en)
*
|
2014-06-06 |
2015-12-10 |
Newport Research, Inc. |
Oil-free and fat-free aqueous suspensions of cyclosporin
|
|
US20160250351A1
(en)
|
2014-06-13 |
2016-09-01 |
Mayo Foundation For Medical Education And Research |
Treating Lymphomas
|
|
EP3834889A1
(en)
|
2014-06-16 |
2021-06-16 |
Mayo Foundation for Medical Education and Research |
Treating myelomas
|
|
CA2959660A1
(en)
|
2014-09-03 |
2016-03-10 |
Genesegues, Inc. |
Therapeutic nanoparticles and related compositions, methods, and systems
|
|
US9446148B2
(en)
|
2014-10-06 |
2016-09-20 |
Mayo Foundation For Medical Education And Research |
Carrier-antibody compositions and methods of making and using the same
|
|
US11324800B2
(en)
|
2015-01-15 |
2022-05-10 |
Wellspring Ophthalmics, Inc. |
Aqueous suspensions of cyclosporin
|
|
US20200237859A1
(en)
|
2019-01-25 |
2020-07-30 |
Newport Research, Inc. |
Aqueous suspensions of cyclosporin
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
EP3302423B1
(en)
|
2015-06-04 |
2022-05-25 |
Crititech, Inc. |
Particle production system and particle collection device
|
|
PL3998069T3
(pl)
|
2015-06-29 |
2025-03-31 |
Abraxis Bioscience, Llc |
Nanocząsteczki zawierające syrolimus i albuminę do zastosowania w leczeniu nowotworów z komórek nabłonkowatych
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
CA2998483C
(en)
|
2015-09-16 |
2022-09-06 |
Dfb Soria, Llc |
Delivery of drug nanoparticles and methods of use thereof
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
CN105412024B
(zh)
*
|
2015-12-14 |
2018-03-30 |
广州帝奇医药技术有限公司 |
靶向疏水性抗肿瘤药物纳米制剂及其制备方法
|
|
WO2017120501A1
(en)
|
2016-01-07 |
2017-07-13 |
Mayo Foundation For Medical Education And Research |
Methods of treating cancer with interferon
|
|
JP6953414B2
(ja)
*
|
2016-01-20 |
2021-10-27 |
フラリー パウダーズ エルエルシーＦｌｕｒｒｙ Ｐｏｗｄｅｒｓ，Ｌｌｃ |
親油性成分を含む吸入に好適な分散性の噴霧乾燥粉末を製造する方法
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
WO2017139698A1
(en)
|
2016-02-12 |
2017-08-17 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
US11305020B2
(en)
|
2016-03-21 |
2022-04-19 |
Mayo Foundation For Medical Education And Research |
Methods for reducing toxicity of a chemotherapeutic drug
|
|
EP3432928A4
(en)
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
PROCESS FOR IMPROVING THE THERAPEUTIC INDEX FOR CHEMOTHERAPEUTIC
|
|
BR112018069628A2
(pt)
|
2016-04-04 |
2019-02-12 |
Crititech, Inc. |
métodos para tratamento de tumor sólido
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
CN105944109B
(zh)
*
|
2016-05-03 |
2019-06-11 |
四川大学 |
一种肾小球靶向的蛋白纳米颗粒药物组合物及其用途
|
|
WO2018038253A1
(ja)
*
|
2016-08-26 |
2018-03-01 |
哲治 奥野 |
微小ナノ化薬剤およびその利用
|
|
CA3035377A1
(en)
|
2016-09-01 |
2018-03-08 |
Mayo Foundation For Medical Education And Research |
Nanoparticle compositions for targeting t-cell cancers
|
|
CN109890419A
(zh)
|
2016-09-01 |
2019-06-14 |
梅约医学教育与研究基金会 |
用于治疗癌症的载体-pd-l1结合剂组合物
|
|
US11590098B2
(en)
|
2016-09-06 |
2023-02-28 |
Mayo Foundation For Medical Education And Research |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
WO2018048816A1
(en)
|
2016-09-06 |
2018-03-15 |
Mayo Foundation For Medical Education And Research |
Methods of treating pd-l1 expressing cancer
|
|
EP3509643A1
(en)
|
2016-09-06 |
2019-07-17 |
Mayo Foundation for Medical Education and Research |
Paclitaxel-albumin-binding agent compositions and methods for using and making the same
|
|
US20190247357A1
(en)
*
|
2016-10-10 |
2019-08-15 |
Abraxis Bioscience, Llc |
Nanoparticle formulations and methods of making and using thereof
|
|
WO2018170196A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
|
|
EP3615145B1
(en)
|
2017-06-09 |
2024-05-15 |
Crititech, Inc. |
Compositions for use in the treatment of epithelial cysts by intracystic injection of antineoplastic particles
|
|
WO2018231908A1
(en)
|
2017-06-14 |
2018-12-20 |
Crititech, Inc. |
Methods for treating lung disorders
|
|
WO2019010316A1
(en)
*
|
2017-07-07 |
2019-01-10 |
Dfb Pharmaceuticals, Llc |
TREATMENT OF HYPERPLASIC TISSUE GROWTH COMPRISING BENIGN PROSTATIC HYPERPLASIA (HBP) BY DIRECT INJECTION OF ANTINOPLASTIC AGENT
|
|
CN107510600A
(zh)
*
|
2017-08-07 |
2017-12-26 |
苏州大学 |
一种制备药用固体微粒的设备及方法
|
|
KR20250057947A
(ko)
|
2017-10-03 |
2025-04-29 |
크리티테크, 인크. |
암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
|
|
US11819488B2
(en)
|
2018-02-23 |
2023-11-21 |
Rhnanopharma |
Nanosuspensions of salsalate and methods of using the same
|
|
US11497726B2
(en)
|
2018-03-16 |
2022-11-15 |
Dfb Soria, Ll. |
Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
|
|
IL277402B1
(en)
|
2018-03-20 |
2026-04-01 |
Abraxis Bioscience Llc |
Methods for treating central nervous system disorders using administration of MTOR inhibitor nanoparticles and albumin
|
|
MX2020011166A
(es)
|
2018-04-25 |
2022-10-19 |
Ethris Gmbh |
Agentes crioprotectores para formulaciones en forma de particulas.
|
|
US20190351031A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
|
EP3982939A1
(en)
*
|
2019-06-14 |
2022-04-20 |
Folium Biosciences Europe B.V. |
Method for micro-encapsulation of natural ingredients by means of contacting with supercritical gas
|
|
JP7832108B2
(ja)
|
2019-10-28 |
2026-03-17 |
アブラクシス バイオサイエンス， エルエルシー |
アルブミンおよびラパマイシンの医薬組成物
|
|
JP2024534175A
(ja)
*
|
2021-10-14 |
2024-09-18 |
スカイ・セラピューティクス・カンパニー・リミテッド |
有機物、無機物またはこれらの塩からなるナノ分子会合体及びその製造方法
|
|
KR102526793B1
(ko)
*
|
2021-11-03 |
2023-04-28 |
주식회사 에스엔바이오사이언스 |
입도분포 유지 안정성이 개선된 알부민 결합 탁산 나노입자 제조방법
|
|
CN116672300A
(zh)
*
|
2022-02-23 |
2023-09-01 |
苏州博创同康医药科技有限公司 |
一种载药纤维材料及其制备方法和用途
|
|
EP4504165A1
(en)
|
2022-04-05 |
2025-02-12 |
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale |
Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer
|
|
EP4501320A1
(en)
*
|
2023-08-02 |
2025-02-05 |
IQ medical GmbH |
A method of preparing an aqueous dispersion of nanoparticles
|
|
KR102683810B1
(ko)
*
|
2024-03-26 |
2024-07-11 |
큐어라벨 주식회사 |
글루타치온, 아스코빅애씨드 및 항산화 활성을 가지는 유용성 생리활성물질을 포함하는 나노 입자의 제조방법 및 이를 함유하는 화장료 조성물
|